Influence of medical treatment, smoking and disease activity on pregnancy outcomes in Crohn's disease

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 3, 2014, Pages 302-308

  Julsgaard, Mette ^a   Nørgaard, Mette ^a   Hvas, Christian Lodberg ^a   Grosen, Anne ^a   Hasseriis, Sara ^a   Christensen, Lisbet Ambrosius ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Crohn's disease; Disease activity; Inflammatory bowel disease; Medical treatment; Pregnancy; Pregnancy outcome; Smoking

Indexed keywords

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; CONGENITAL ABNORMALITIES; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDUCTION CHEMOTHERAPY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; LOGISTIC MODELS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; STILLBIRTH;

EID: 84894123250     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.879200     Document Type: Article

References (40)

1. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998;114:1161-8.
2. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998;93:2426-30.
3. Vermeire S, Carbonnel F, Coulie PG, Geenen V, Hazes JM, Masson PL, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis 2012;6:811-23.
4. Manosa M, Navarro-Llavat M, Marin L, Zabana Y, Cabre E, Domenech E. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol 2013;48:427-32.
5. Nielsen MJ, Norgaard M, Holland-Fisher P, Christensen LA. Self-reportedantenataladherencetomedicaltreatmentamong pregnant women with Crohn's disease. Aliment Pharmacol Ther 2010;32:49-58.
6. Jharap B, De Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, et al. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 2013 Feb. 19.[Epub ahead of print]
7. Bortlik M, Machkova N, Duricova D, Malickova K, Hrdlicka L, Lukas M, et al. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-alpha therapy during pregnancy: three-center study. Scand J Gastroenterol 2013;48:951-8.
8. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013;11:286-92.
9. World Health Organization. The prevention of perinatal mortality and morbidity. Geneva, Switzerland: 1970; Report No.: 457.
10. Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 2007;102:1947-54.
11. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007;56:830-7.
12. Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH. Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring. Inflamm Bowel Dis 2010;16:847-55.
13. Molnar T, Farkas K, Nagy F, Lakatos PL, Miheller P, Nyari T, et al. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study. Scand J Gastroenterol 2010;45:1302-6.
14. Schmidt LS, Schuz J, Lahteenmaki P, Trager C, Stokland T, Gustafson G, et al. Fetal growth, preterm birth, neonatal stress and risk for CNS tumors in children: a Nordic populationand register-based case-control study. Cancer Epidemiol Biomarkers Prev 2010;19:1042-52.
15. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-8.
16. Klassifikation af Sygdomme, 10. revision 1. udgave (international Classification of Disease, 10th rev. 1st. ed) Copenhagen: National Board of Health; 1993.
17. Knudsen LB, Olsen J. The Danish medical birth registry. Dan med Bull 1998;45:320-3.
18. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843-8.
19. Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Crohn's disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 2010;8:509-15.
20. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sorensen HT. Predictive value and completeness of the registration of congenital abnormalities in threeDanish populationbased registries. Scand J Public Health 2003;31:12-16.
21. Vohr BR, Tyson JE, Wright LL, Perritt RL, Li L, Poole WK. Maternal age, multiple birth, and extremely low birth weight infants. J Pediatr 2009;154:498-503.
22. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
23. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010;2:273-9.
24. Julsgaard M, Norgaard M, Hvas CL, Buck D, Christensen LA. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflamm Bowel Dis 2011;17:1573-80.
25. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009;15:720-5.
26. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a populationbased cohort study. Am J Gastroenterol 2002;97:641-8.
27. Moser MA, Okun NB, Mayes DC, Bailey RJ. Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol 2000;95:1021-6.
28. Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn's disease as defined by clinical variables. Dig Dis Sci 2007;52:2897-903.
29. Russel MG, Volovics A, Schoon EJ, Van Wijlick EH, Logan RF, Shivananda S, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998;4:182-6.
30. Coelho J, Beaugerie L, Colombel JF, Hebuterne X, Lerebours E, Lemann M, et al. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 2011;60:198-203.
31. Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, et al. The effect on the fetus of medications used to treat pregnant inflammatory boweldisease patients. Am J Gastroenterol 2004;99:656-61.
32. Norgard B, Fonager K, Pedersen L, Jacobsen BA, Sorensen HT. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 2003;52:243-7.
33. Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007;102:1406-13.
34. Van Der Woude CJ, Kolacek S, Dotan I, Oresland T, Vermeire S, Munkholm P, et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010;4:493-510.
35. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancyoutcomes inwomenwith inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007;133:1106-12.
36. Pedersen N, Bortoli A, Duricova D, Inca D, Panelli MR, Gisbert JP, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther 2013;38:501-12.
37. Fonager K, Sorensen HT, Rasmussen SN, Moller-Petersen J, Vyberg M. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol 1996;31:154-9.
38. Kristensen J, Langhoff-Roos J, Skovgaard LT, Kristensen FB. Validation of the Danish birth registration. J Clin Epidemiol 1996;49:893-7.
39. Knudsen LB. Paritetsoplysningen i Sundhedsstyrelsens medicinske fødselsregister. (Information on parity in the medical registry of births of the National Board of Health). 1993.
40. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, et al. Patient non-adherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-44.